Related Experiment Video
Updated: May 5, 2026
A Mouse Model to Assess Innate Immune Response to Staphylococcus aureus Infection
Published on: February 28, 2019
A multivalent mRNA-LNP cocktail vaccine confers superior efficacy against Staphylococcus aureus infection in murine
Xingyue Gao1, Yueling Zheng1, Xingyun Wang1
1Department of Pharmacology, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
Abstract:
Staphylococcus aureus has been posing a significant global health threat, underscoring an urgent need for innovative preventive strategies, notably vaccines. This study presents an evaluation of a multi-target mRNA vaccine against S. aureus, engineered to target five pivotal virulence factors: the manganese transporter MntC, enterotoxin SEB, exotoxin HLA, adhesion factor FnBPA, and iron surface binding protein IsdB. In a parallel control setting, mice were immunized with either monovalent mRNA-LNPs, a multivalent mRNA-LNP cocktail, or a protein cocktail, and were subsequently assessed for humoral and cellular immune responses as well as the vaccines' protective efficacy. The findings demonstrated that the multivalent mRNA-LNP cocktail vaccine induced a robust and sustained humoral immune response, along with a stronger cellular immune response compared to both monovalent mRNA vaccines and the protein cocktail vaccine. This was characterized by increased secretion of IFN-γ, IL-2, IL-4, and IL-17A, suggesting a potent Th1/Th2/Th17 mixed immune response. Moreover, the cocktail vaccine demonstrated improved survival rates and a reduction in bacterial loads and organ damage. These results underscore the promise of a multi-target mRNA vaccine strategy in combating antibiotic-resistant Staphylococcus aureus.
Insights
A novel multi-target mRNA vaccine effectively combats Staphylococcus aureus by stimulating strong immune responses. This vaccine shows promise in protecting against antibiotic-resistant strains, reducing bacterial load and improving survival rates in mice.
Area of Science:
- Immunology
- Vaccinology
- Microbiology
Background:
- Staphylococcus aureus presents a significant global health challenge, necessitating advanced preventive measures like vaccines.
- The rise of antibiotic-resistant strains further amplifies the need for innovative therapeutic strategies.
Purpose of the Study:
- To evaluate a novel multi-target mRNA vaccine designed to elicit protective immunity against Staphylococcus aureus.
- To assess the vaccine's efficacy by targeting key virulence factors: MntC, SEB, HLA, FnBPA, and IsdB.
Main Methods:
- Mice were immunized with a multivalent mRNA-LNP cocktail vaccine, monovalent mRNA-LNPs, or a protein cocktail.
- Humoral and cellular immune responses, including cytokine secretion (IFN-γ, IL-2, IL-4, IL-17A), were analyzed.
- Vaccine protective efficacy was determined by survival rates, bacterial loads, and organ damage assessment.
Main Results:
- The multivalent mRNA-LNP cocktail vaccine induced robust humoral and enhanced cellular immune responses compared to controls.
- A potent Th1/Th2/Th17 mixed immune response was observed, indicated by increased cytokine secretion.
- The cocktail vaccine significantly improved survival rates and reduced bacterial burden and organ damage.
Conclusions:
- Multi-target mRNA vaccines represent a promising strategy for combating Staphylococcus aureus infections, including antibiotic-resistant strains.
- This approach effectively stimulates comprehensive immune responses, offering enhanced protection.
More Related Videos
12:53Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
07:32Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
Published on: September 1, 2023
